Status
Conditions
Treatments
About
Participants had randomly divided into two equal groups. Group (A) which is the control group receive normal routine medication. Group (B) will receive normal routine medication with the treatment program of moderate intensity upper limb ergometer for 15 minute with frequency three times per week for four weeks.
Full description
Control group (A):
Each participant will sign a consent form after receiving a detailed explanation about the procedure.
A blood sample will been taken by a nurse in a heparinized tube and delivered to lab within six hours.
BMI will been measured body weight(Kg) and height (m2)
a. BMI= body weight (Kg)/ height (m2).
Waist circumference will be measured.
After one month blood analysis evaluation will be done to record the response to the routine medication.
Training Procedure for group (B):
Each participant will sign a consent form after receiving a detailed explanation about the procedure.
A blood sample will been taken by a nurse in a heparinized tube and delivered to lab within six hours.
BMI will been measured body weight(Kg) and height (m2)
a. BMI= body weight (Kg)/ height (m2).
Waist circumference will be measured.
The maximum heart rate will be determined from Tanaka formula (208- 0.7 *age of the participant)
Start with sitting resting without any effort for 5 min then Start at a low speed and intensity for 5 minutes to warm up the body.
Increase the speed and intensity for 10-30 seconds before dropping it back for 2-5 minutes and Repeat according to the intensity.
Finally, a five minutes of cooling down with no resistance had performed.
After one month blood analysis evaluation will be done to record the response to the routine medication.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
40 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal